Arthur Taveras - Feb 13, 2024 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role
Chief Scientific Officer
Signature
/s/ Adam S. Mostafa, attorney-in-fact
Stock symbol
XFOR
Transactions as of
Feb 13, 2024
Transactions value $
$0
Form type
4
Date filed
2/16/2024, 05:08 PM
Previous filing
Feb 12, 2024
Next filing
Mar 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XFOR Stock Appreciation Right Award $0 +428K $0.00 428K Feb 13, 2024 Common Stock 428K $0.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of February 13, 2024, subject to the Reporting Person remaining an employee of the Issuer through and including each applicable vesting date.